TRINITY & BOWTHORPE MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: D82017 | NORWICH, NR2 2BG
Showing results 101-150 of 611
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 480 | 58.3K | £1.9K | +1.2% vs avg | |
| Latanoprost | 477 | 2,105 | £1.2K | -1.7% vs avg |
| Flucloxacillin sodium | 474 | 18.4K | £1.1K | +5.4% ▲ |
| Loperamide hydrochloride | 466 | 30.4K | £667 | +100.1% ▲ |
| Estradiol | 466 | 11.6K | £5.4K | +72.7% ▲ |
| Ferrous sulfate | 463 | 19.4K | £631 | -10.0% ▼ |
| Promethazine hydrochloride | 460 | 14.1K | £2.0K | +28.7% ▲ |
| Quinine sulfate | 457 | 13.4K | £1.8K | +57.8% ▲ |
| Other emollient preparations | 449 | 252.2K | £3.4K | -25.2% ▼ |
| Esomeprazole | 441 | 18.7K | £1.1K | +9.0% ▲ |
| Pantoprazole | 437 | 18.9K | £876 | +59.0% ▲ |
| Diltiazem hydrochloride | 424 | 21.3K | £3.5K | +38.1% ▲ |
| Estriol | 422 | 8,015 | £4.3K | +98.3% ▲ |
| Solifenacin | 419 | 12.9K | £502 | -12.2% ▼ |
| Aripiprazole | 416 | 10.3K | £1.5K | +63.5% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 406 | 52.3K | £2.5K | +125.9% ▲ |
| Mesalazine (Systemic) | 405 | 45.8K | £23.4K | +69.1% ▲ |
| Mirabegron | 405 | 11.6K | £10.7K | +0.8% vs avg |
| Lactulose | 402 | 218.5K | £2.0K | +22.1% ▲ |
| 390 | 46.7K | £1.6K | +41.0% ▲ | |
| Progesterone | 386 | 27.2K | £5.2K | -7.8% ▼ |
| 373 | 4,940 | £1.4K | +78.5% ▲ | |
| Alginic acid compound preparations | 368 | 199.3K | £2.4K | -37.2% ▼ |
| Mometasone furoate | 363 | 407 | £3.2K | -9.6% ▼ |
| Sodium valproate | 351 | 79.6K | £5.8K | +10.4% ▲ |
| Oxycodone hydrochloride | 349 | 36.4K | £7.5K | +36.4% ▲ |
| Tirzepatide | 347 | 360 | £34.8K | +78.7% ▲ |
| Glyceryl trinitrate | 345 | 744 | £839 | +45.9% ▲ |
| Sitagliptin | 334 | 10.7K | £677 | -14.4% ▼ |
| Sumatriptan succinate | 326 | 3,505 | £9.1K | -7.9% ▼ |
| Ranolazine | 320 | 18.8K | £3.4K | +88.3% ▲ |
| Lithium carbonate | 319 | 13.6K | £2.3K | +151.4% ▲ |
| Clobetasone butyrate | 319 | 14.1K | £2.5K | +56.3% ▲ |
| Warfarin sodium | 317 | 18.3K | £621 | -32.8% ▼ |
| Trimethoprim | 316 | 18.7K | £980 | +54.7% ▲ |
| Risperidone | 315 | 14.5K | £2.2K | +24.5% ▲ |
| Topiramate | 308 | 19.8K | £2.4K | +73.3% ▲ |
| Beclometasone dipropionate | 308 | 317 | £861 | +43.2% ▲ |
| 305 | 36.8K | £1.5K | +132.8% ▲ | |
| Mebeverine hydrochloride | 299 | 26.9K | £1.0K | -3.7% ▼ |
| Hyoscine butylbromide | 296 | 22.1K | £2.0K | +27.0% ▲ |
| Hydroxychloroquine sulfate | 296 | 14.7K | £855 | +52.9% ▲ |
| 296 | 3,484 | £806 | +18.6% ▲ | |
| Azathioprine | 290 | 15.8K | £464 | +167.6% ▲ |
| Bimatoprost | 287 | 2,670 | £2.4K | +93.1% ▲ |
| Combined ethinylestradiol 30mcg | 283 | 37.8K | £1.7K | +1.9% vs avg |
| Digoxin | 277 | 8,502 | £613 | -26.8% ▼ |
| Paroxetine hydrochloride | 277 | 11.9K | £810 | +48.4% ▲ |
| Procyclidine hydrochloride | 277 | 6,740 | £307 | +95.8% ▲ |
| Methylphenidate hydrochloride | 273 | 10.6K | £10.3K | +5.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.